U.S. drug developer Capricor places Duchenne drug trial on hold

Capricor Therapeutics Inc said on Wednesday it had put on hold a clinical trial of its drug to treat Duchenne muscular dystrophy (DMD), a muscle-wasting disorder, citing a safety review.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news